Nephrology

The treatment is approved for patients who have a moderate to high risk of recurrence, following nephrectomy or nephrectomy accompanied by surgical resection of metastatic lesions.

Health Canada approves adjunct treatment for chronic kidney disease based on two trial results.

Selecting medications to manage hyperglycemia . . . and comorbidities,

An oral anticoagulant is recommended for most patients aged ≥ 65 years with nonvalvular atrial fibrillation (NVAF), to reduce the risk of stroke.

Practice a tool compares drug interactions with the four marketed DOACs, focusing on interactions commonly encountered in thrombosis/cardiology-based practices

Horizon Pharma will be forced to lower the price on its life-saving Procysbi medication, after the Patented Medicines Prices Review Board (PMPRB) decided the $300,000-a-year drug was too expensive. 

For many of the Canadian physicians on Team Canada this is their first trip outside the country in two years.

GLP-1 receptor agonists and SGLT2 inhibitors have proven cardiorenal benefits in patients with and without type 2 diabetes.